Abiomed, Inc.
ABMD · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $106,133 | $54,554 | $60,325 | $45,752 |
| Dep. & Amort. | $6,724 | $6,620 | $7,290 | $6,926 |
| Deferred Tax | -$1,043 | -$6,373 | -$4,636 | -$1,144 |
| Stock-Based Comp. | $16,014 | $13,362 | $11,989 | $12,383 |
| Change in WC | -$38,978 | -$671 | $1,974 | $14,417 |
| Other Non-Cash | -$75,429 | $611 | $2,030 | $12,153 |
| Operating Cash Flow | $13,421 | $68,103 | $78,972 | $90,487 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,609 | -$6,783 | -$14,891 | -$6,478 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$151,105 | -$126,488 | -$217,003 | -$251,218 |
| Inv. Sales/Matur. | $258,281 | $141,385 | $139,320 | $77,675 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $101,567 | $8,114 | -$92,574 | -$180,021 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1,531 | $0 | $8,822 |
| Stock Repurch. | -$112,106 | -$14,517 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$110,182 | -$23,936 | $4,745 | -$6,161 |
| Financing Cash Flow | -$110,182 | -$23,936 | $4,745 | -$6,161 |
| Forex Effect | -$2,963 | -$4,607 | -$2,580 | -$1,932 |
| Net Chg. in Cash | $1,843 | $47,674 | -$11,437 | -$97,627 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $180,492 | $132,818 | $144,255 | $241,882 |
| End Cash | $182,335 | $180,492 | $132,818 | $144,255 |
| Free Cash Flow | $7,812 | $61,320 | $64,081 | $84,009 |